Developing an Infrastructure and Performing Vaccine Effectiveness Studies for Covid-19 Vaccine in the EU/EEA | Tenderlake

Developing an Infrastructure and Performing Vaccine Effectiveness Studies for Covid-19 Vaccine in the EU/EEA

Contract Value:
EUR 2M - 2M
Notice Type:
Contract award notice
Published Date:
12 February 2021
Closing Date:
Location(s):
SE SVERIGE (SE Sweden/SVERIGE)
Description:
Developing an Infrastructure and Performing Vaccine Effectiveness Studies for Covid-19 Vaccine in the EU/EEA

Developing an infrastructure and performing vaccine effectiveness studies for Covid-19 vaccine in the EU/EEA.


Project Monitoring and Study Designs and Methods for Assessment of Covid‐19 Vaccine Effectiveness

Project monitoring and study designs and methods for assessment of Covid‐19 vaccine effectiveness. Services.


Vaccine Effectiveness Studies within a Hospital Based System

Vaccine effectiveness studies within a hospital based system. Services.


Other Studies to Assess Vaccine Effectiveness

Other studies to assess vaccine effectiveness.


Infrastructure of an Outpatient Based System to Assess Vaccine Effectiveness

Infrastructure of an outpatient based system to assess vaccine effectiveness. Services.

Awarded to:
Establishing Severe Acute Respiratory Infections (SARI) Surveillance and Performing Hospital-based Covid-19 Transmission Studies
Epiconcept SAS, Paris (FR)
Download full details as .pdf
The Buyer:
European Centre for Disease Prevention and Control
CPV Code(s):
85100000 - Health services